Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G, Comella G. Daponte A, et al. Among authors: ascierto pa. Anticancer Res. 2005 Mar-Apr;25(2B):1441-7. Anticancer Res. 2005. PMID: 15865103 Free article. Clinical Trial.
Adjuvant treatment of malignant melanoma: where are we?
Ascierto PA, Scala S, Ottaiano A, Simeone E, de Michele I, Palmieri G, Castello G. Ascierto PA, et al. Crit Rev Oncol Hematol. 2006 Jan;57(1):45-52. doi: 10.1016/j.critrevonc.2005.05.002. Epub 2005 Jun 28. Crit Rev Oncol Hematol. 2006. PMID: 15990330 Review.
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF. Ascierto PA, et al. J Clin Oncol. 2005 Oct 20;23(30):7660-8. doi: 10.1200/JCO.2005.02.0933. J Clin Oncol. 2005. PMID: 16234528 Clinical Trial.
Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G. Ottaiano A, et al. Among authors: ascierto pa. Cytokine. 2006 Feb 7;33(3):150-5. doi: 10.1016/j.cyto.2006.01.002. Epub 2006 Mar 6. Cytokine. 2006. PMID: 16517174
Human melanoma metastases express functional CXCR4.
Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G. Scala S, et al. Among authors: ascierto pa. Clin Cancer Res. 2006 Apr 15;12(8):2427-33. doi: 10.1158/1078-0432.CCR-05-1940. Clin Cancer Res. 2006. PMID: 16638848
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
Casula M, Colombino M, Satta MP, Cossu A, Lissia A, Budroni M, Simeone E, Calemma R, Loddo C, Caracò C, Mozzillo N, Daponte A, Comella G, Canzanella S, Guida M, Castello G, Ascierto PA, Palmieri G; Italian Melanoma Intergroup. Casula M, et al. Among authors: ascierto pa. Eur J Cancer. 2007 Jan;43(1):137-43. doi: 10.1016/j.ejca.2006.07.017. Epub 2006 Oct 19. Eur J Cancer. 2007. PMID: 17055252
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
Palmieri G, Satriano SM, Budroni M, Cossu A, Tanda F, Canzanella S, Caracò C, Simeone E, Daponte A, Mozzillo N, Comella G, Castello G, Ascierto PA. Palmieri G, et al. Among authors: ascierto pa. BMC Cancer. 2006 Nov 15;6:266. doi: 10.1186/1471-2407-6-266. BMC Cancer. 2006. PMID: 17107608 Free PMC article.
710 results